Streamlining Haemophilia Care in India: The Need for STGs

Medical experts recently emphasized the urgent need for national standard treatment guidelines (STGs) to modernize haemophilia care in India. Currently, the country identifies fewer than one in five patients suffering from this rare genetic bleeding disorder. Consequently, nearly 80% of cases remain undetected, highlighting a massive gap in screening systems. Strengthening awareness and diagnostic infrastructure is therefore essential for better patient outcomes.

Improving Early Diagnosis for Haemophilia Care in India

Clotting factor protein deficiencies cause haemophilia, specifically Factor VIII in type A and Factor IX in type B. These conditions lead to prolonged bleeding from even minor injuries or surgeries. Interestingly, spontaneous genetic mutations cause nearly one-third of all cases. This factor makes the diagnostic process more complex for many clinicians. Furthermore, doctors often misdiagnose children with arthritis, which results in permanent joint damage. Early identification remains the only way to prevent such avoidable complications. For those looking to specialize in managing such complex blood disorders, enrolling in a Certification Course In Hematology can provide the necessary expertise to improve diagnostic accuracy.

Transitioning from On-Demand to Prophylaxis

Traditionally, treatment approaches in India have remained reactive. Most patients seek medical help only after a painful bleeding episode occurs. However, recent clinical advances have shifted the focus toward preventive care or prophylaxis. Newer non-factor therapies, which patients receive subcutaneously, significantly reduce bleeding frequency. Although these therapies are easier to administer, access remains limited. Specifically, only about 4% of Indian patients receive prophylaxis, compared to 80-90% in high-income nations.

The Role of India-Specific Treatment Guidelines

Experts argue that India-specific guidelines will provide a uniform framework for long-term management. These standards must account for local resource constraints and various social contexts. For instance, the Gujarat government has already successfully implemented a prophylaxis-first model. Consequently, national STGs would ensure that all patients receive equitable access to life-saving care. Ultimately, standardizing these protocols will reduce disability and improve the overall quality of life for the haemophilia community. As clinical practices evolve, practitioners can stay ahead by exploring specialized hematology courses that bridge the gap between global standards and local implementation.

Frequently Asked Questions

Q1: Why is haemophilia underdiagnosed in India?

Haemophilia is underdiagnosed because many hospitals lack the necessary screening capabilities for blood clotting. Additionally, mild cases may go unnoticed until a patient undergoes a major surgery or tooth extraction.

Q2: What is the main difference between prophylaxis and on-demand treatment?

Prophylaxis involves regular treatment to prevent bleeding before it starts. On-demand therapy only provides treatment after a bleeding episode has occurred, which can lead to cumulative joint damage over time.

Q3: How do India-specific guidelines help in managing the disorder?

India-specific guidelines account for local resource limitations and geographical challenges. They provide a standardized path for diagnosis and management that works within the Indian healthcare infrastructure. For comprehensive training on improving patient outcomes through evidence-based protocols, consider the Postgraduate Diploma In Haematology.

References

1. Experts urge standard treatment guidelines to streamline haemophilia care inIndia – ETHealthworld
2. National Health Mission (NHM). (2024). Guidelines on Hemoglobinopathies and Hemophilia.
3. World Federation of Hemophilia (WFH). (2020). Guidelines for the Management of Hemophilia, 3rd edition.

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.